Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × Dasatinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Specimen Handling 4 Biopsy 4 Magnetic Resonance Spectroscopy 3 belinostat 2 X-Rays 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 talimogene laherparepvec 1 sodium-iodide symporter 1 cemiplimab 1 Whole-Body Irradiation 1 Spinal Puncture 1 Photons 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 MEDI-570 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 CTLA-4 Antigen 1 Bendamustine Hydrochloride 1 Azacitidine 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡